BG107196A - Лечение на разстройства, свързани със серотонергичната система - Google Patents

Лечение на разстройства, свързани със серотонергичната система Download PDF

Info

Publication number
BG107196A
BG107196A BG107196A BG10719602A BG107196A BG 107196 A BG107196 A BG 107196A BG 107196 A BG107196 A BG 107196A BG 10719602 A BG10719602 A BG 10719602A BG 107196 A BG107196 A BG 107196A
Authority
BG
Bulgaria
Prior art keywords
treatment
anxiety
dose
use according
daily dose
Prior art date
Application number
BG107196A
Other languages
Bulgarian (bg)
English (en)
Inventor
Harri Kanerva
Outi Maki-Okola
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of BG107196A publication Critical patent/BG107196A/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG107196A 2000-03-17 2002-10-15 Лечение на разстройства, свързани със серотонергичната система BG107196A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00302207A EP1133986A1 (en) 2000-03-17 2000-03-17 Use of deramciclane for the treatment of anxiety and depression
PCT/FI2001/000266 WO2001068067A2 (en) 2000-03-17 2001-03-16 Use of deramciclane for the treatment of anxiety and depression

Publications (1)

Publication Number Publication Date
BG107196A true BG107196A (bg) 2003-02-28

Family

ID=8172804

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107196A BG107196A (bg) 2000-03-17 2002-10-15 Лечение на разстройства, свързани със серотонергичната система

Country Status (19)

Country Link
EP (2) EP1133986A1 (pt)
JP (1) JP2004500394A (pt)
KR (1) KR20020089399A (pt)
CN (1) CN1418094A (pt)
AR (1) AR028260A1 (pt)
AU (2) AU4838301A (pt)
BG (1) BG107196A (pt)
BR (1) BR0109172A (pt)
CA (1) CA2403350A1 (pt)
CZ (1) CZ20023025A3 (pt)
EA (1) EA200200987A1 (pt)
HU (1) HUP0204528A3 (pt)
IL (1) IL151493A0 (pt)
MX (1) MXPA02008998A (pt)
NO (1) NO20024331L (pt)
PL (1) PL359288A1 (pt)
SK (1) SK12982002A3 (pt)
WO (1) WO2001068067A2 (pt)
ZA (1) ZA200207111B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
CN105497020A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物的光学异构体治疗疼痛的医药用途
CN109758452A (zh) * 2014-09-25 2019-05-17 石药集团中奇制药技术(石家庄)有限公司 胺类化合物治疗疼痛的医药用途
CN105497021A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物治疗焦虑障碍的医药用途
CN105456257A (zh) * 2014-09-25 2016-04-06 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物的光学异构体治疗焦虑障碍的医药用途

Also Published As

Publication number Publication date
NO20024331D0 (no) 2002-09-10
HUP0204528A3 (en) 2004-08-30
NO20024331L (no) 2002-09-10
SK12982002A3 (sk) 2003-05-02
EP1133986A1 (en) 2001-09-19
AU2001248383A1 (en) 2002-07-16
KR20020089399A (ko) 2002-11-29
CZ20023025A3 (cs) 2003-05-14
AR028260A1 (es) 2003-04-30
AU4838301A (en) 2001-09-24
WO2001068067A3 (en) 2002-07-11
PL359288A1 (en) 2004-08-23
MXPA02008998A (es) 2003-04-25
EA200200987A1 (ru) 2003-04-24
JP2004500394A (ja) 2004-01-08
WO2001068067A2 (en) 2001-09-20
IL151493A0 (en) 2003-04-10
CA2403350A1 (en) 2001-09-20
CN1418094A (zh) 2003-05-14
EP1263424A2 (en) 2002-12-11
BR0109172A (pt) 2002-11-26
ZA200207111B (en) 2003-12-04
HUP0204528A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
Lane et al. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache
US6395788B1 (en) Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
US5166202A (en) Method for the treatment of panic disorder
JP2002541097A (ja) 線維筋痛症及び関連症状の治療におけるフルピルチン
Georgotas et al. Trazodone hydrochloride: A wide spectrum antidepressant with a unique pharmacological profile: A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology
Nelson et al. The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials
US5447948A (en) Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
EA028300B1 (ru) Композиции, содержащие вортиоксетин и донепезил
Edmonds et al. A review of suvorexant, doxepin, ramelteon, and tasimelteon for the treatment of insomnia in geriatric patients
EP0282818A2 (en) The use of gepirone for preparing a pharmaceutical composition for the treatment of atypical depression
Rizvi et al. Chlorpheniramine, an old drug with new potential clinical applications: a comprehensive review of the literature
JP2005537307A (ja) のぼせの治療のためのレボキセチンの使用
BG107196A (bg) Лечение на разстройства, свързани със серотонергичната система
Rapaport et al. Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.
Lapierre A review of trimipramine 30 years of clinical use
Kasvikis et al. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects
US20120010242A1 (en) Low dose pipamperone in treating mood disorders
CN109069466A (zh) 5-ht6受体拮抗剂用于治疗阿尔茨海默病伴情感淡漠共病
EP2236138A1 (en) Low dose pipamperone in treating mood and anxiety disorders
US6589996B2 (en) Treatment of disorders relating to the serotonergic system
EP2236157A1 (en) Pipamperone and a second agent in treating mood and anxiety disorders
US20030153612A1 (en) Method of treatment or prophylaxis of restless legs syndrome with ropinirole compound
Amsterdam et al. Once-versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study
TW201806599A (zh) 用於快速開始抗抑鬱作用之給藥方案